Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Non-cash Items (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Non-cash Items for 7 consecutive years, with $656386.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 19.88% year-over-year to $656386.0, compared with a TTM value of $656386.0 through Sep 2025, up 19.88%, and an annual FY2024 reading of $701975.3, up 647.64% over the prior year.
  • Non-cash Items was $656386.0 for Q3 2025 at Sanara MedTech, up from $31013.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.4 million in Q1 2024 and bottomed at $11500.0 in Q1 2021.
  • Average Non-cash Items over 5 years is $312046.9, with a median of $124191.0 recorded in 2023.
  • The sharpest move saw Non-cash Items skyrocketed 1567.83% in 2024, then crashed 98.73% in 2025.
  • Year by year, Non-cash Items stood at $11500.0 in 2021, then surged by 1171.23% to $146191.0 in 2022, then crashed by 35.77% to $93892.0 in 2023, then skyrocketed by 647.64% to $701975.3 in 2024, then fell by 6.49% to $656386.0 in 2025.
  • Business Quant data shows Non-cash Items for SMTI at $656386.0 in Q3 2025, $31013.0 in Q2 2025, and $31013.0 in Q1 2025.